ANCA相关性血管炎伴血清补体C3降低的临床分析  

Clinical analysis of anti-neutrophil cytoplasmic antibody-associated vasculitis with low serum complement C3 levels

作　　者：谢丽娇[1] 张瑞[2] 贺江花 唐莎[1] 王卫黎 刘星[1] 张均[1] 李芙蓉[1] 张静波[1] 

机构地区：[1]第三军医大学新桥医院肾内科,重庆400037 [2]解放军273医院门诊部,库尔勒841000

出　　处：《免疫学杂志》2017年第5期410-414,421,共6页Immunological Journal

基　　金：第三军医大学新桥医院临床科研基金(2014YLC06);重庆市社会民生科技创新专项(cstc2015shmszx120029)

摘　　要：目的探讨血清补体C3(serum complement C3,sC3)降低的抗中性粒细胞胞浆抗体相关性血管炎(AAV)患者的临床病理特征及预后。方法回顾性分析2011年1月至2016年3月我院肾内科穿刺活检确诊的54例AAV患者的临床及病理资料。采用免疫比浊法检测sC3,以我院sC3测值的正常范围下线值为截点将AAV患者分成低sC3组(sC3<0.9 g/L)与正常sC3组(sC3≥0.9 g/L),比较2组患者流行病学、实验室检查、肾脏病理、临床症状、治疗及预后的差异。结果低sC3组,血肌酐基线值明显高于正常sC3组(P=0.008);C反应蛋白、eGFR值明显低于正常sC3组(P值分别<0.001、0.012);快速肾功能衰竭以及即时透析的发生率明显高于正常sC3组(P值分别为0.035、0.014);缓解率显著低于正常sC3组(P<0.001)。Kaplan-Meier生存分析显示低sC3组的肾脏累积生存率明显低于正常sC3组(log-rank=10.197,P=0.001)。结论血清补体C3降低的AAV患者病情严重,进展较快,预后差。To investigate the clinicopathological features and outcomes of anti-neutrophil cytoplasmicantibody（ANCA）-associated vasculitis（AAV） with low serum complement C3（sC3） levels, total of 54 patients withAAV underwent renal biopsy were analyzed by retrospective observational study in our department from January2011 to March 2016. The sC3 levels of AAV patients were determined by immunoturbidimetric method, then thepatients were divided into two groups of the low sC3 group（sC3〈0.9 g/L） and the normal sC3 group（sC3≥0.9 g/L）based on the lower limit of sC3 normal range. The patients were compared in baseline variables, laboratory data,clinical symptoms, histological features and therapeutic outcomes after treatments. Data showed that patients with lowersC3 presented a higher level of initial serum creatinine than patients with normal sC3（P=0.008）. The levels of c-reactiveprotein and eGFR were significant lower in low sC3 group than those in normal sC3 group（P〈0.001, 0.012, respectively）.Furthermore, the incidences of rapid progressive renal failure and renal replacement therapy at diagnosis were highersignificantly in the low sC3 group than those in normal sC3 level group（P=0.035, 0.014, respectively）. However, theincidence of remission was lower in the low sC3 level group than that in normal sC3 level group（P〈0.001）. The low sC3 group showed worse renal survival than normal sC3 level group（log-rank=10.197, P=0.001） confirmed by patients with low sC3 levels tend to have severe renalimpairment with a rapid progression and poor prognosis.

关 键 词：ANCA相关性血管炎 血清补体C3 预后 

分 类 号：R593.2[医药卫生—内科学]